시장보고서
상품코드
1152254

세계의 정밀 정신의학 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 바이오마커별, 샘플별, 기술별, 용도별, 최종 사용자별, 기업별, 지역별(2017-2027년)

Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Biomarkers, By Sample, By Technology, By Application, By End User, By Company and By Region

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 115 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 정밀 정신의학 시장 규모는 예측기간 중 2023-2027년에 눈부신 성장을 이룰 것으로 예측되고 있습니다.

시장 성장의 주요 요인은 정신 질환 발병률의 상승과 기술 진보 등 요인이 시장 성장을 뒷받침하고 있습니다. 시장 성장을 지원하는 기타 요인으로는 인지도 향상, 투자 확대, 인구 증대, 라이프 스타일 변화, 시퀀스 비용 감소, 무기 성장 전략 채택 증가, 의료 인프라에 대한 정부 지원 등이 있습니다. 합니다. 또한 정신 질환 발병 및 징후와 관련된 게놈 프로테오믹스 분석을 실시하는 연구자에 의한 고도의 분자 진단 기술의 높은 도입률도 시장 성장을 촉진할 것으로 기대되는 주요 요인입니다.

세계의 정밀 정신의학(Precision Psychiatry) 시장에 대해 조사 분석했으며, 부문별·지역별 시장 규모/점유율 예측/시장 역학/기업 개요 등 체계적인 정보를 제공하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계 정밀 정신의학 시장에 미치는 영향

제5장 VOC(고객의 목소리)

제6장 세계의 정밀 정신의학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 바이오마커별(유전자, 단백질)
    • 샘플별(혈액 베이스, 혈액 베이스 이외)
    • 기술별(시퀀싱, 폴리머라제 연쇄반응, 마이크로어레이, 면역분석, 기타)
    • 용도별(알츠하이머병, 파킨슨병, 자폐증, 우울증, 기타)
    • 최종 사용자별(병원·클리닉, 학술·조사기관, 기타)
    • 기업별(2021년)
    • 지역별
  • 제품 시장 맵

제7장 북미의 정밀 정신의학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 바이오마커별
    • 샘플별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 유럽의 정밀 정신의학시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 바이오마커별
    • 샘플별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 아시아 태평양의 정밀 정신의학시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 바이오마커별
    • 샘플별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 아시아 태평양 : 국가별 분석
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주

제10장 남미의 정밀 정신의학시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 바이오마커별
    • 샘플별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동·아프리카의 정밀 정신의학 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 바이오마커별
    • 샘플별
    • 기술별
    • 용도별
    • 최종 사용자별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카
    • 사우디 아라비아
    • 아랍 에미리트 연방
    • 이집트
    • 터키

제12장 시장 역학

  • 촉진 요인
  • 과제

제13장 시장 동향과 개발

제14장 경쟁 상황

  • Altimate Healthcare
  • PsyProtix, Inc
  • Cerebral-Alto Nanoscience
  • Precision Psychiatric Services, Inc
  • Tempus Labs, Inc.
  • Curis AI Inc.

제15장 전략적 제안

LYJ 22.11.24

The global precision psychiatry market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in incidences of mental health and technological advancements, which are bolstering the market growth, globally. Precision psychiatry is new field within precision medicine, which seeks to detect and capitalize on individual differences in biology, environment, lifestyle, and social determinants of health to improve mental health prevention, diagnosis, and treatment. The other factors supporting the market's growth are increasing awareness, growing investments, increase in population, changing lifestyle, decreasing cost of sequencing, increasing adoption of inorganic growth strategies and support from governments for healthcare infrastructure. Also, the high adoption of advanced molecular diagnostic technologies by the researchers to conduct genomic and proteomic analysis associated to the onset and manifestation of psychiatric illnesses are some of the key factors that are projected to bolster the market growth.

Increase in Prevalence of Mental Disorders

Over the past few years, rise in number of people suffering from mild or severe depressive disorders is seen. These mental illness or disorders are basically caused due to chemical, genetic, and anatomical conditions, or psychological origins such as trauma. Thus, to seek better lives for those suffering from mental illness, precision psychiatry is much required, which attributes to the growth of the market, globally. For instance, according to the National Institute of Mental Health, around one in every five U.S. adults suffer from mental illness. Also, in 2020, 25.8% of females were suffering from mental illness.

Increasing Adoption of Inorganic Growth Strategies

Increasing inorganic growth strategies by key players are expected to drive the global precision psychiatry market growth during the forecast period. For instance, in 2021, Alto Neuroscience announced its emergence from stealth with $40 million in funding to advance the largest clinical-stage pipeline of precision psychiatry medicines. Similarly, in 2021, Atai Life Sciences, a biotech company in the psychedelics space, announced the formation of a new subsidiary, called PsyProtix, which is a precision psychiatry company.

Increased demand for Genomics as precision psychiatry

From past few years, genomic technologies have advanced the understanding of neuropsychiatric disorders. Genomics plays a significant part in the diagnosis of several genetic disorders. It has ample scope in precision psychiatry as it can advocate medical management constructed on the genetic face of a person with the help of clinical data and AI. It incorporates DNA sequencing methods, recombinant DNA, and bioinformatics for sequencing, assembling, and analyzing the structure and functions of genomes. Many severe mental illnesses, such as schizophrenia and bipolar disorder, are highly inherited, and have a complex pattern of inheritance. These diseases can be identified by using sequencing technology, which evaluates the rare genetic variants. With the use of sequencing technology, psychiatry can ultimately reshape by predicting disease risk and lead to better understanding of aetiology, prognosis, or treatment response. Moreover, the decrease in cost of sequencing is also a key factor to increase the growth of the market.

Market Segmentation

The global precision psychiatry market is segmented into biomarkers, sample, technology, application, end user, and company. Based on biomarker, the market is divided into genetic and protein. Based on sample, the market is divided into blood-based and non-blood-based. Based on non-blood-based, the market is further divided into saliva, urine, cerebral spinal fluid, and others. Based on technology, the market is divided into sequencing, polymerase chain reaction, microarray, immunoassay, and others. Based on application, the market is divided into Alzheimer's disease, Parkinson's disease, autism, depression, and others. Based on end user, the market is divided into hospital & clinics, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in incidences of mental illness in the country.

Market Players

Altimate Healthcare, PsyProtix, Inc, Cerebral-Alto Nanoscience, Precision Psychiatric Services, Inc, Tempus Labs, Inc., and Curis AI Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global precision psychiatry market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Precision Psychiatry Market, By Biomarker:

  • Genetic
  • Protein

Precision Psychiatry Market, By Sample:

  • Blood Based
  • Non-Blood-Based
    • Saliva
    • Urine
    • Cerebral Spinal Fluid
    • Others
    • Precision Psychiatry Market, By Technology:
  • Sequencing
  • Polymerase Chain Reaction
  • Microarray
  • Immunoassay
  • Others

Precision Psychiatry Market, By Application:

  • Alzheimer's Disease
  • Parkinson's Disease
  • Autism
  • Depression
  • Others

Precision Psychiatry Market, By End User:

  • Hospital & Clinics
  • Academic & Research Institutions
  • Others

Precision Psychiatry Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in precision psychiatry market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Precision Psychiatry Market

5. Voice of Customer

6. Global Precision Psychiatry Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Biomarkers (Genetic v/s Protein)
    • 6.2.2. By Sample (Blood Based v/s Non-Blood-Based)
      • 6.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
    • 6.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
    • 6.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
    • 6.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. North America Precision Psychiatry Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Biomarkers (Genetic v/s Protein)
    • 7.2.2. By Sample (Blood Based v/s Non-Blood-Based)
      • 7.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
    • 7.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
    • 7.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
    • 7.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Precision Psychiatry Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Biomarker
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Mexico Precision Psychiatry Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Biomarker
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Canada Precision Psychiatry Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Biomarker
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User

8. Europe Precision Psychiatry Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Biomarkers (Genetic v/s Protein)
    • 8.2.2. By Sample (Blood Based v/s Non-Blood-Based)
      • 8.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
    • 8.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
    • 8.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
    • 8.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Precision Psychiatry Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Biomarker
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Precision Psychiatry Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Biomarker
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Precision Psychiatry Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Biomarker
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Precision Psychiatry Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Biomarker
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Precision Psychiatry Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Biomarker
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Asia-Pacific Precision Psychiatry Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Biomarkers (Genetic v/s Protein)
    • 9.2.2. By Sample (Blood Based v/s Non-Blood-Based)
      • 9.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
    • 9.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
    • 9.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
    • 9.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Precision Psychiatry Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Biomarker
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. India Precision Psychiatry Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Biomarker
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Korea Precision Psychiatry Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Biomarker
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. Japan Precision Psychiatry Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Biomarker
        • 9.3.4.2.2. By Sample
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Precision Psychiatry Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Biomarker
        • 9.3.5.2.2. By Sample
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. South America Precision Psychiatry Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Biomarkers (Genetic v/s Protein)
    • 10.2.2. By Sample (Blood Based v/s Non-Blood-Based)
      • 10.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
    • 10.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
    • 10.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
    • 10.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Precision Psychiatry Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Biomarker
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Precision Psychiatry Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Biomarker
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Precision Psychiatry Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Biomarker
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Middle East and Africa Precision Psychiatry Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Biomarkers (Genetic v/s Protein)
    • 11.2.2. By Sample (Blood Based v/s Non-Blood-Based)
      • 11.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
    • 11.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
    • 11.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
    • 11.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Precision Psychiatry Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Biomarker
        • 11.3.1.2.2. By Sample
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Precision Psychiatry Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Biomarker
        • 11.3.2.2.2. By Sample
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Precision Psychiatry Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Biomarker
        • 11.3.3.2.2. By Sample
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User
    • 11.3.4. Egypt Precision Psychiatry Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Biomarker
        • 11.3.4.2.2. By Sample
        • 11.3.4.2.3. By Technology
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By End User
    • 11.3.5. Turkey Precision Psychiatry Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Biomarker
        • 11.3.5.2.2. By Sample
        • 11.3.5.2.3. By Technology
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Altimate Healthcare
  • 14.2. PsyProtix, Inc
  • 14.3. Cerebral-Alto Nanoscience
  • 14.4. Precision Psychiatric Services, Inc
  • 14.5. Tempus Labs, Inc.
  • 14.6. Curis AI Inc.

15. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제